GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.66M | -10.91M | -11.96M | -11.25M | -10.01M |
| Total Depreciation and Amortization | 3.00K | 4.00K | 4.00K | 4.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 648.00K | 654.00K | 841.00K | 811.00K | 380.00K |
| Change in Net Operating Assets | -1.41M | -1.89M | 925.00K | 1.22M | 455.00K |
| Cash from Operations | -10.42M | -12.14M | -10.19M | -9.21M | -9.17M |
| Capital Expenditure | -3.00K | -3.00K | -3.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -3.00K | -3.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.83M | 22.38M | 15.56M | 9.94M | 9.35M |
| Repurchase of Common Stock | -2.00K | -2.00K | -2.00K | -1.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.59M | -2.47M | -2.17M | -1.41M | -1.41M |
| Cash from Financing | 16.24M | 19.91M | 13.39M | 8.52M | 7.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.83M | 7.77M | 3.20M | -691.00K | -1.23M |